论文部分内容阅读
近十年来,随着联合化疗的进展和支持疗法的改善,急性白血病(以下简称急白)的缓解率显著提高,生存期亦明显延长。本文分析急自78例以探讨急白的临床发展变化规律及有利的预后因素,现将结果报告如下。材料和方法我科自1976～1984年共收治急白92例,其中住院不足两周或联合化疗不足2个疗程者14例予以剔除,7例供临床分析。全部病例均符合1978年全国白血病座谈会标准。1979～1984年病例做了FAB形态学分类。急自患者骨髓粒系祖细胞(CFU-C)生长类型按Moore标准划分(n。I型为集落生长型、Ⅱ型为丛生长型(未细分大丛和小丛),Ⅲ型
In the past decade, with the progress of combined chemotherapy and the improvement of supportive therapy, the acute leukemia (hereinafter referred to as acute white) significantly improved the remission rate, survival was significantly prolonged. This article analyzes the urgency since 78 cases to explore the rapid change of clinical development and favorable prognostic factors, the results are reported as follows. Materials and Methods From 1976 to 1984, our department received a total of 92 cases of sudden white, of which 14 cases were hospitalized less than two weeks or combined chemotherapy less than 2 courses were removed, 7 cases for clinical analysis. All cases are in line with the 1978 National Leukemia Symposium standards. 1979-1984 cases made FAB morphological classification. The type of growth of acute myeloid granulocyte-derived progenitor cells (CFU-C) was classified according to Moore’s criteria (n.I type was colony growth type, type II was clumpy type (undivided large plexus and small plexus), type III